Results 51 to 60 of about 786,314 (373)

A systematic review of criteria used to report complications in soft tissue and oncologic surgical clinical research studies in dogs and cats. [PDF]

, 2020
ObjectiveTo evaluate reporting of surgical complications and other adverse events in clinical research articles describing soft tissue and oncologic surgery in dogs and cats.Study designSystematic literature review.SampleEnglish-language articles ...
Balsa, Ingrid M, Culp, William TN, Follette, Christelle M, Giuffrida, Michelle A, Mayhew, Philipp D, Oblak, Michelle L, Singh, Ameet, Steffey, Michele A   +7 more
core   +1 more source

Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database

Thrombosis Journal, 2022
Background Tigecycline has broad-spectrum anti-bacterial activity and often used for critically ill patients with complicated infections. Only a few clinical studies have reported the coagulation disorder induced by tigecycline. The aim of this study was
M. Guo, Jin-wei Liang, Dandan Li, Ying Zhao, Wanyi Xu, Lei Wang, Xiaohui Cui   +6 more
semanticscholar   +1 more source

A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab

Expert Opinion on Drug Safety, 2022
Romosozumab is a novel drug for the treatment of osteoporosis. The adverse reactions of romosozumab still need to be explored. The FDA Adverse Event Reporting System (FAERS) provides an enormous dataset for adverse events (AEs) analysis. AEs registered in FAERS between January 2019 and December 2020 were collected for this study.
Zepeng Chen, Ming Li, Shuzhen Li, Yuxi Li, Junyan Wu, Kaifeng Qiu, Xiaoxia Yu, Lin Huang, Guanghui Chen   +8 more
openaire   +2 more sources

A logic programming approach to medical errors in imaging [PDF]

, 2011
Background: In 2000, the Institute of Medicine reported alarming data on the scope and impact of medical errors calling the public attention. One solution to this problem is the adoption of adverse event reporting and learning systems that can help to ...
Alves, Victor, Brandão, Paulo, Nelas, Luís, Neves, José, Rodrigues, Susana Isabel Magalhães da Rocha   +4 more
core   +1 more source

Thromboembolic events in Janus kinase inhibitors: A pharmacovigilance study from 2012 to 2021 based on the Food and Drug Administration's Adverse Event Reporting System

British Journal of Clinical Pharmacology, 2022
As a new type of drug developed rapidly in recent years, Janus kinase inhibitors (JAKinibs) have caused controversy due to possible adverse reactions of thromboembolism.
Ziwei Dong, X. Ye, Chenxin Chen, Rui Wang, Dongxu Liu, Xiao Xu, Xiang Zhou, Jia He   +7 more
semanticscholar   +1 more source

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system

Saudi Medical Journal, 2015
To assess completeness of reports in the Saudi Adverse Event Reporting System (SAERS), which is a part of the Saudi Food and Drug Authority pharmacovigilance system for monitoring the safety of medications.A cross-sectional study was conducted in Riyadh, Saudi Arabia using the reports that were received between December 2009 and June 2012 in the SAERS.
Waad H. Al-Kathiri, Hervé Le Louet, Hisham Aljadhey, Thamir M. Alshammari   +3 more
openaire   +3 more sources

Adverse events among Ontario home care clients associated with emergency room visit or hospitalization: a retrospective cohort study [PDF]

, 2013
Background: Home care (HC) is a critical component of the ongoing restructuring of healthcare in Canada. It impacts three dimensions of healthcare delivery: primary healthcare, chronic disease management, and aging at home strategies.
Baker, G. Ross, Blais, Régis, Dill, Donna, Doran, Diane M., Droppo, Lisa, Foebel, Andrea Dawn, Gruneir, Andrea, Heckman, George A., Hirdes, John P., Jantzi, Micaela, Lacroix, Hélène, Li, Xiaoqiang, McIsaac, Corrine, Mitchell, Lori, Nahm, Sang-Myong, O'Beirne, Maeve, Poss, Jeffrey W., Qian, Gan, White, Nancy, Yim, Odilia   +19 more
core   +1 more source

Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives

JMIR Medical Informatics, 2014
BackgroundThe Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) is a repository of spontaneously-reported adverse drug events (ADEs) for FDA-approved prescription drugs.
Polepalli Ramesh, Balaji, Belknap, Steven M, Li, Zuofeng, Frid, Nadya, West, Dennis P, Yu, Hong   +5 more
doaj   +1 more source

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database

Frontiers in Pharmacology, 2022
Objectives: As fall events and injuries have become a growing public health problem in older patients and the causes of falls are complex, there is an emerging need to identify the risk of drug-induced falls. Methods: To mine and analyze the risk signals
Shuang Zhou, Boying Jia, Jiahe Kong, Xiaolin Zhang, Lili Lei, Zhenhui Tao, Ling-yue Ma, Q. Xiang, Ying Zhou, Yi-min Cui   +9 more
semanticscholar   +1 more source

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system

Frontiers in Pharmacology, 2023
Background: Apalutamide is a new drug class, which is approved to treat prostate cancer (PCa). The aim of our study was to assess the safety profiles of apalutamide in real-world through data mining of the United States Food and Drug Administration ...
Zhihong Fang, Zhiqiang Xu, Wei Zhu, Mingming Yu, Chunmei Ji   +4 more
doaj   +1 more source